The nonsteroidal anti-inflammatory drug, nabumetone, differentially inhibits β-catenin signaling in the MIN mouse and azoxymethane-treated rat models of colon carcinogenesis

Hemant K. Roy(Mymensingh Medical College Hospital), Thomas C. Smyrk(Mayo Clinic in Arizona), Anne Ratashak(University of Nebraska Medical Center), William J. Karolski(University of Nebraska Medical Center), John Hart(University of Chicago Medical Center), Ramesh K. Wali(Boston University)
Cancer Letters
September 17, 2004
Cited by 7


Related Papers